Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 3—March 2024
Research

Monitoring and Characteristics of Mpox Contacts, Virginia, USA, May–November 2022

Eleanor N. FieldComments to Author , Elizabeth McCarty, Dawn Saady, and Brandy Darby
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (E.N. Field); Virginia Department of Health, Richmond, Virginia, USA (E.N. Field, E. McCarty, D. Saady, B. Darby)

Main Article

Table 2

Exposure risk categories and likelihood of developing mpox among 991 persons included in mpox contact tracing and symptom monitoring cohort, Virginia, USA, May 1–November 1, 2022*

Risk category No. (%) persons
 χ2 (d.f.)† p value
Total Persons without mpox Persons with mpox
None 12 (1.2) 12 (1.3) 0
Lower 360 (37.1) 357 (37.8) 3 (11.1) 39.7 (2) <0.001
Intermediate 374 (38.5) 370 (39.2) 4 (14.8)
High 225 (23.2) 205 (21.7) 20 (74.1)
Missing 20 19 1

*Calculated percentages exclude missing values. Predetermined categories were defined by the nature of the exposure using criteria defined by the Centers for Disease Control and Prevention (10). †χ2 analysis excludes persons in the none category.

Main Article

References
  1. Alakunle  E, Moens  U, Nchinda  G, Okeke  MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses. 2020;12:1257. DOIPubMedGoogle Scholar
  2. Kumar  N, Acharya  A, Gendelman  HE, Byrareddy  SN. The 2022 outbreak and the pathobiology of the monkeypox virus. J Autoimmun. 2022;131:102855. DOIPubMedGoogle Scholar
  3. Philpott  D, Hughes  CM, Alroy  KA, Kerins  JL, Pavlick  J, Asbel  L, et al.; CDC Multinational Monkeypox Response Team. Epidemiologic and clinical characteristics of monkeypox cases—United States, May 17–July 22, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1018–22. DOIPubMedGoogle Scholar
  4. Thornhill  JP, Barkati  S, Walmsley  S, Rockstroh  J, Antinori  A, Harrison  LB, et al.; SHARE-net Clinical Group. Monkeypox virus infection in humans across 16 countries—April–June 2022. N Engl J Med. 2022;387:679–91. DOIPubMedGoogle Scholar
  5. World Health Organization. 2022–-2023 Mpox (monkeypox) outbreak: global trends [cited 2023 Apr 6]. https://who.int/emergencies/situations/monkeypox-oubreak-2022
  6. Centers for Disease Control and Prevention. 2022–2023 U.S. map & case count [cited 2023 Dec 1]. https://www.cdc.gov/poxvirus/mpox/response/2022/us-map.html
  7. Centers for Disease Control and Prevention. Vaccination [cited 2023 Jan 11]. https://www.cdc.gov/poxvirus/monkeypox/interim-considerations/overview.html
  8. Centers for Disease Control and Prevention. Monkeypox virus infection case definition [cited 2023 Feb 22]. https://ndc.services.cdc.gov/case-definitions/monkeypox-virus-infection
  9. Centers for Disease Control and Prevention. 2022/2023 U.S. mpox outbreak short case report form. [cited 2023 Nov 10]. https://www.cdc.gov/poxvirus/mpox/pdf/scrf-short-form.pdf
  10. Centers for Disease Control and Prevention. Monitoring and risk assessment for persons exposed in the community [cited 2022 Dec 13]. archive.cdc.gov/www_cdc_gov/poxvirus/mpox/clinicians/monitoring.html
  11. Minhaj  FS, Singh  V, Cohen  SE, Townsend  MB, Scott  H, Szumowski  J, et al. Prevalence of undiagnosed monkeypox virus infections during global mpox outbreak, United States, June–September 2022. Emerg Infect Dis. 2023;29:2307–14. DOIPubMedGoogle Scholar

Main Article

Page created: January 18, 2024
Page updated: February 22, 2024
Page reviewed: February 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external